With HarrisMartin's Testosterone Therapy Litigation Report, you will be the first to know about critical developments in this emerging area of drug litigation. The report includes coast-to-coast coverage of AndroDerm, Depo Testosterone, AndroGel, Testim and other Testosterone products Click Here to Subscribe Now). This publication is offered exclusively online.
Current Drugs & Medical Devices subscribers receive this supplement at no extra charge. To set up access to the report, call (800) 496-4319. Those who do not currently subscribe to the Drugs & Medical Devices report can Click Here for Access
Testosterone Therapy - Issue: 1
Judicial Panel Creates Centralized Docket in Illinois for Federal Testosterone Replacement Therapy Lawsuits
Drug Makers Move to Dismiss All Testosterone Therapy Lawsuits Pending in Illinois Federal Court
Lawsuit Says Pfizer’s Depo Testosterone Caused Louisiana Man’s Anxiety, Heart Problems
Plaintiffs Challenge Pre-Service Removal of Fortesta Testosterone Therapy Lawsuit
Testosterone Therapy Plaintiffs Urge JPML to Assign Recently Appointed Judge to Federal Coordinated Docket
Testosterone Drug Axiron Caused Calif. Man’s Congestive Heart Failure, Lawsuit Says
Judicial Panel Announces Details for Hearing on Motion to Combine Testosterone Therapy Lawsuits
Testosterone Therapy Fortesta Caused Ga. Man’s Pulmonary Thromboembolism, Lawsuit Alleges
